Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1651–1700 of 18397
On April 10, 2025, the Company appointed Robert J. Cardin, age 61, to serve as the Company’s Interim Chief Financial Officer, effective as of the Transition Date
the Company announced the departure of Michael Shane Paladin, the Company’s President and Chief Executive Officer (“CEO”) and member of the Company’s Board of Directors (the “Board”) effective April 9, 2025.
The Company has appointed John Dorman, the Company’s Chairperson of the Board (“Board Chair”), as the Company’s interim President and interim Chief Executive Officer (together, “Interim CEO”), effective as of April 9, 2025.
Anthony Doyle, the Chief Financial Officer and Interim Principal Accounting Officer of BioCryst Pharmaceuticals, Inc. (the “Company”) notified the Company of his intention to resign from his employment with the Company, effective April 9, 2025
appointed Jon P. Stonehouse, the Company’s Chief Executive Officer, to serve as Interim Chief Financial Officer and Interim Principal Accounting Officer, effective as of the Effective Date.
On April 10 2025, the Board of Directors of the Company appointed Mark Frost to serve as Interim Chief Financial Officer and Treasurer effective upon Ms. Cote’s resignation (the “Effective Date”).
On April 7, 2025, Jennifer Cote notified the Company of her resignation as Chief Financial Officer and Treasurer.
On April 10, 2025, Allison Transmission Holdings, Inc. (the “Company” or “Allison”) announced the appointment of Scott A. Mell to serve as the Company’s Chief Financial Officer and Treasurer, effective April 14, 2025.
will be succeeded by James (Jim) Nickolas as of the Transition Date
Oddone Incisa, the Company’s Chief Financial Officer, will step down effective May 6, 2025
On April 4, 2025, at a meeting (the “ Meeting ”) of the board of directors (the “ Board ”) of Graphjet Technology (the “ Company ”), Aiden Lee Ping Wei resigned from his positions as Chief Executive Officer and member of the Board of the Company (the “ CEO Resignation ”).
the Board appointed Chris Lai Ther Wei, who had previously been appointed to the positions of Deputy Chief Executive Officer and Chief Financial Officer of the Company, as Chief Executive Officer
On April 10, 2025, the Board appointed Marcello Padula to serve as the Chief Financial Officer of the Company, effective on May 7, 2025.
On April 4, 2025, Robert Folino notified the board of directors (the “Board”) of Bleichroeder Acquisition Corp. I (the “Company”) of his resignation as Chief Financial Officer of the Company, effective on May 7, 2025.
Mr. Topper will continue to serve as the Company’s Chief Financial Officer until the effective date of Ms. Vairavan’s appointment and will provide transition support through his departure on May 15, 2025.
On April 10, 2025, Arcutis Biotherapeutics, Inc. (the “Company”) announced the appointment of Latha Vairavan, the Company’s current Vice President, Finance and Corporate Controller, as the Company’s Senior Vice President and Chief Financial Officer, effective immediately prior to the filing of the Company’s Quarterly Report on Form 10-Q for the three months ending March 31, 2025 with the Securities and Exchange Commission.
On April 7, 2025, Fariyal Khanbabi ceased to be employed as Chief Financial Officer of Microvast Holdings, Inc.
On April 3, 2025, the Company made an offer of employment to Carl T. “Pat” Schultz pursuant to which Mr. Schultz will serve as the Company’s Chief Financial Officer
On April 9, 2025 Neogen Corporation (the “Company”) announced that John Adent, the Company’s CEO and President, will be stepping down.
On April 8, 2025, Littelfuse, Inc. (the “Company”) and Meenal Sethna, Executive Vice President and Chief Financial Officer of the Company, agreed to Ms. Sethna’s separation from employment with the Company, effective September 1, 2025 (the “Separation Date”).
On April 7, 2025, the Board of Directors of Madison Square Garden Entertainment Corp. (the “Company”) appointed David Collins as Executive Vice President and Chief Financial Officer effective April 14, 2025
the board of directors of National Research Corporation, a Delaware corporation (the “Company”) appointed Trent Green as our Chief Executive Officer and to serve as a director, both effective June 1, 2025.
the appointment of Todd Yoder as the Company’s Executive Vice President, Chief Financial Officer and Treasurer, effective April 14, 2025.
On March 21, 2025, Jessica Buss notified Argo Group International Holdings, Inc. (the “Company”) of her resignation as Chief Executive Officer of the Company, effective immediately.
On April 7, 2025, the Board of Directors of the Company also determined that Thomas F. Cowhey, currently the Executive Vice President and Chief Financial Officer of CVS Health, will cease to serve as Executive Vice President and Chief Financial Officer of CVS Health as of the Effective Date.
On April 7, 2025, the Board of Directors of CVS Health Corporation (the “Company” or “CVS Health”) appointed Brian O. Newman to serve as Executive Vice President and Chief Financial Officer of CVS Health, effective May 12, 2025 (the “Effective Date”).
On April 4, 2025, HireQuest, Inc. (the "Company") appointed, effective May 31, 2025, C. David Hartley to serve as Chief Financial Officer.
Steve Crane, the Company's Chief Financial Officer, informed the Company of his intention to retire from his role effective May 31, 2025.
On April 4, 2025, Kanwardev Raja Singh Bal notified indie Semiconductor, Inc. (the “Company”) of his resignation as Chief Financial Officer, Executive Vice President and Chief Accounting Officer of the Company.
On April 3, 2025, the Board of Directors (the “ Board ”) of the Company determined by unanimous written consent to appoint Ms. Dai as the Company’s permanent Chief Financial Officer (“ CFO ”), effective April 3, 2025.
On April 3, 2025, the Board appointed Jennifer Sy, age 40, as the Company’s Chief Accounting Officer and principal financial officer, effective as of April 4, 2025.
On April 3, 2025, the Board formally appointed Mr. Fischer to serve as Interim President, Chief Executive Officer and principal executive officer of the Company, effective as of April 4, 2025.
On April 6, 2025, Edward M. Christie, III, President, Chief Executive Officer and director of Spirit Aviation Holdings, Inc. (the “Company”), stepped down from his role with the Company and the Board of Directors (the “Board”).
Scott Kent, Vice President of Finance, will succeed Mr. Oxley as CFO, effective July 1, 2025.
Timothy M. Oxley, Chief Financial Officer (“CFO”) of MasterCraft Boat Holdings, Inc. (the “Company”) announced his resignation as CFO, effective June 30, 2025
On April 2, 2025, Peter A. Scott informed Healthpeak Properties, Inc. (the “Company”) of his resignation from his position as Chief Financial Officer of the Company.
On March 31, 2025, John Sperzel notified the Company of his termination of that certain Consulting Agreement between himself and the Company, dated February 15, 2025 and his resignation from his position as the Company’s Chief Executive Officer and President.
On April 3, 2025, John Sprague notified the Company of his resignation from his position as the Company’s Chief Financial Officer and Corporate Treasurer.
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.
Ms. Christina L. Zamarro, Executive Vice President and Chief Financial Officer of the Company, will lead the EMEA business unit on an interim basis in addition to her duties as Chief Financial Officer.
On April 2, 2025, the Board appointed Martin Sjolund to succeed Mr. Atal as the Company’s President and Chief Executive Officer, effective on June 17, 2025, immediately following the 2025 Annual Meeting.
On April 2, 2025, Vikram A. Atal, President and Chief Executive Officer of PRA Group, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to retire as President and Chief Executive Officer and as a member of the Board, effective on June 17, 2025, immediately following the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
- Mr. Onorati was appointed by the Board as the chief executive officer of the Company.
The Board of Directors of ImmuCell Corporation (the Company) has elected Timothy C. Fiori, age 46, to serve as its Chief Financial Officer effective April 7, 2025.
appointed Matthew Stark as the Company’s Chief Financial Officer and a member of the Board of Directors.
accepted the resignation from Andrew Kucharchuk as the Company’s Chief Financial Officer and member of the Board of Directors.
On April 1, 2025, the Board of Directors of Healthcare Realty Trust Incorporated (the “Company”) appointed Peter A. Scott as the Company’s President and Chief Executive Officer, effective April 15, 2025.
Upon Mr. Park becoming the Chief Financial Officer, Gloria Nelund's tenure as the Company’s interim Chief Financial Officer ended and she continues in her longstanding positions as Chairman, President, and Chief Executive Officer of the Company.
On March 28, 2025, the board of managers (the “Board”) of TriLinc Global Impact Fund, LLC (the “Company”) appointed Kun Yong (Brent) Park, age 43, to serve as the Chief Financial Officer of the Company, effective as of April 1, 2025.
On the Closing Date, April 1, 2025, Mr. Takehiro Abe resigned from his positions as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.